CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +3,000 | $106.02 | $318K | 10,507 |
| 2024-03-13 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −3,000 | $140.14 | $420K | 7,507 |
| 2024-03-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −3,000 | $106.02 | $318K | 4,367 |
| 2024-03-11 | POPS RICHARD F Director | Option exercise 10b5-1 | +100 | $42.76 | $4K | 29,612 |
| 2024-03-11 | POPS RICHARD F Director | Sale 10b5-1 | −100 | $140.00 | $14K | 29,512 |
| 2024-03-11 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −100 | $42.76 | $4K | 23,200 |
| 2024-03-11 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +200 | $106.02 | $21K | 7,707 |
| 2024-03-11 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −200 | $140.00 | $28K | 7,507 |
| 2024-03-11 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −200 | $106.02 | $21K | 7,367 |
| 2024-03-08 | POPS RICHARD F Director | Option exercise 10b5-1 | +1,700 | $42.76 | $73K | 31,212 |
| 2024-03-08 | POPS RICHARD F Director | Sale 10b5-1 | −1,700 | $140.05 | $238K | 29,512 |
| 2024-03-08 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −1,700 | $42.76 | $73K | 23,300 |
| 2024-03-08 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +1,800 | $106.02 | $191K | 9,307 |
| 2024-03-08 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −1,800 | $140.03 | $252K | 7,507 |
| 2024-03-08 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −1,800 | $106.02 | $191K | 7,567 |
| 2024-02-29 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +273 | $79.02 | $22K | 7,780 |
| 2024-02-29 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −273 | $135.51 | $37K | 7,507 |
| 2024-02-29 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −273 | $79.02 | $22K | 5,444 |
| 2024-02-28 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +2,500 | $79.02 | $198K | 10,007 |
| 2024-02-28 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −2,500 | $135.64 | $339K | 7,507 |
Page 35 of 49 · 963 trades